What is Calcivis?
Headquartered in Edinburgh, United Kingdom, Calcivis specializes in the development of advanced imaging systems designed to transform dental diagnostics. The company's core technology enables clinicians to visualize demineralization in real-time, allowing for the implementation of targeted preventive treatments before irreversible damage occurs. By bridging the gap between clinical observation and patient-specific preventive care, Calcivis occupies a unique position in the dental technology landscape, addressing a critical need for objective, data-driven diagnostic tools in modern dentistry.
How much funding has Calcivis raised?
Calcivis has raised a total of $26.8M across 9 funding rounds:
Grant
$505K
Private Equity
$1.3M
Multiple Rounds
$13.2M
Private Equity
$1.3M
Other Financing Round
$2.2M
Unspecified
$2M
Other Financing Round
$6.3M
Grant (2014): $505K, investors not publicly disclosed
Private Equity (2014): $1.3M led by Archangel Informal Investment
Grant (2015): $3M, investors not publicly disclosed
Private Equity (2015): $7M featuring Archangel Investors
Other Financing Round (2015): $3.2M backed by European Commission
Private Equity (2017): $1.3M with participation from Archangel Investors and Julz Co, LLC
Other Financing Round (2019): $2.2M led by European Commission
Unspecified (2021): $2M supported by Archangels, Lynx Financial, and Scottish Enterprise
Other Financing Round (2024): $6.3M featuring Scottish National Investment Bank and Maven Capital Partners UK
Key Investors in Calcivis
Scottish National Investment Bank
A development investment bank providing long-term, patient capital to support innovation, climate change initiatives, and sustainable economic growth across Scotland.
Maven Capital Partners UK
A prominent private equity and venture capital firm focused on scaling high-growth businesses through strategic financial and operational support.
Archangel Investors
A leading business angel syndicate that provides early-stage and follow-on capital to innovative technology companies with high growth potential.
What's next for Calcivis?
With the recent influx of capital, Calcivis is well-positioned to scale its operations and deepen its market penetration. The strategic focus will likely center on expanding the clinical adoption of its imaging platform, enhancing its diagnostic software capabilities, and potentially exploring new geographic markets. As the company transitions into this next phase of growth, the continued support from institutional investors will be instrumental in navigating regulatory landscapes and establishing the company's technology as a standard of care in preventive dentistry. The emphasis remains on delivering long-term value through innovation, ensuring that the company remains at the forefront of the digital health revolution within the oral care sector.
See full Calcivis company page
